A novel variant of ER-alpha, ER-alpha36 mediates testosterone-stimulated ERK and Akt activation in endometrial cancer Hec1A cells.
about
The therapeutic target of estrogen receptor-alpha36 in estrogen-dependent tumorsIcaritin causes sustained ERK1/2 activation and induces apoptosis in human endometrial cancer cellsDifferential ligand binding affinities of human estrogen receptor-α isoformsER-α36, a novel variant of ER-α, mediates estrogen-stimulated proliferation of endometrial carcinoma cells via the PKCδ/ERK pathway.GPER mediates estrogen-induced signaling and proliferation in human breast epithelial cells and normal and malignant breastEstrogen receptor-α36 is involved in pterostilbene-induced apoptosis and anti-proliferation in in vitro and in vivo breast cancerER-α36: a novel biomarker and potential therapeutic target in breast cancer.Alternate estrogen receptors promote invasion of inflammatory breast cancer cells via non-genomic signalingEstrogen receptor α36 mediates a bone-sparing effect of 17β-estrodiol in postmenopausal women.Membrane estrogen signaling enhances tumorigenesis and metastatic potential of breast cancer cells via estrogen receptor-α36 (ERα36)High ERα36 Expression Level and Membrane Location Predict Poor Prognosis in Renal Cell Carcinoma.Estrogens and Male Lower Urinary Tract DysfunctionChaperone gp96 mediates ER-α36 cell membrane expression.The Role of Steroid Sulfatase as a Prognostic Factor in Patients with Endometrial Cancer.Aromatase inhibition: a potential target for the management of recurrent or metastatic endometrial cancer by letrozole: more questions than answers?Role of ER-α36 in breast cancer by typical xenoestrogens.Multiple receptors shape the estrogen response pathway and are critical considerations for the future of in vitro-based risk assessment efforts.Short androgen receptor poly-glutamine-promoted endometrial cancer is associated with benzo[a]pyrene-mediated aryl hydrocarbon receptor activation.Estrogen receptor-α36 is involved in development of acquired tamoxifen resistance via regulating the growth status switch in breast cancer cells.Opposite regulation of estrogen receptor-α and its variant ER-α36 by the Wilms' tumor suppressor WT1.Expression of ERα36 in gastric cancer samples and their matched normal tissues.ERα36, a variant of estrogen receptor α, is predominantly localized in mitochondria of human uterine smooth muscle and leiomyoma cells.The expression of ER, PR in endometrial cancer and analysis of their correlation with ERK signaling pathway.Tamoxifen enhances stemness and promotes metastasis of ERα36+ breast cancer by upregulating ALDH1A1 in cancer cells.Expression of AKT1 along with AKT2 in granulosa-lutein cells of hyperandrogenic PCOS patients.
P2860
Q26829978-91F79BCC-838A-4267-A1F4-FD461CC98284Q28477353-ECFA0C58-BAB1-4BFC-B18E-7A62D3ED01EAQ28487311-E5363DC2-DF13-40CB-8523-EC3DE65C782FQ33747888-D6CF9CCD-1532-4C9C-A12B-66447E3DC09EQ33882180-FEEE047A-5B47-4689-8A09-7163CCAB5919Q34050621-4677DDEC-5D72-458F-B561-CD0329A9854BQ34140162-A0AC1BD5-7584-410B-B99C-C8336A85CB0BQ34147662-E78F4CAC-ACFB-4F53-B6F7-43436800E575Q35229925-8C04C064-0542-4DF2-BA98-6CF1E36FC27BQ35802058-0DB8F681-B859-41E4-A4EB-2EC87229DE14Q35858096-5220FF52-BE11-4002-A386-07F60EA1EEDEQ36518535-781029D7-EEAC-4627-AFC5-41210EA7AFB3Q36544709-FDAE570E-89F8-4366-8664-36AE8AC6B2DCQ36707956-EE4E537B-C1F5-4665-B74B-1C1CBC0EFD8EQ37854068-DC294556-0671-4E09-9F85-84B3D8D181DCQ38580235-F6FA5CA5-3A8F-4CEB-9144-3F8139E6343FQ38663074-295B4A22-E38D-46AA-9857-1A8C1C64BD61Q40092714-997AE2CC-557F-4B26-8FF5-32858C9DD5CBQ41134570-29B68726-8A0B-46C8-8227-E008B8DA25EFQ41975840-6C6AACB1-4278-4B10-82E7-3C8B252E0DA0Q42180742-B1F4CBB7-8B05-4DF8-9E2A-F53AE8E22EFEQ42686787-55A7AFF6-7FF6-4A92-89A8-915B9AD91ECDQ47590366-1226D3D7-98A3-41D1-90BA-531CDE3E4883Q49380281-DCCEFCB0-992B-4070-B6CD-F77B9D18AB3AQ50856309-9E2EFE44-62CB-45BF-940F-CED1F1ED9E5D
P2860
A novel variant of ER-alpha, ER-alpha36 mediates testosterone-stimulated ERK and Akt activation in endometrial cancer Hec1A cells.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on 24 September 2009
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
A novel variant of ER-alpha, E ...... ndometrial cancer Hec1A cells.
@en
A novel variant of ER-alpha, E ...... ndometrial cancer Hec1A cells.
@nl
type
label
A novel variant of ER-alpha, E ...... ndometrial cancer Hec1A cells.
@en
A novel variant of ER-alpha, E ...... ndometrial cancer Hec1A cells.
@nl
prefLabel
A novel variant of ER-alpha, E ...... ndometrial cancer Hec1A cells.
@en
A novel variant of ER-alpha, E ...... ndometrial cancer Hec1A cells.
@nl
P2093
P2860
P356
P1476
A novel variant of ER-alpha, E ...... ndometrial cancer Hec1A cells.
@en
P2093
Li-Ying Yan
Qing-Yuan Sun
Sheng-Li Lin
Xing-Wei Liang
Zhao-Yi Wang
Zhen-Bo Wang
P2860
P2888
P356
10.1186/1477-7827-7-102
P577
2009-09-24T00:00:00Z
P5875
P6179
1038789062